Literature DB >> 10790132

Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City.

J N Steenbergen1, A Casadevall.   

Abstract

Analysis of 40 New York City Cryptococcus neoformans isolates revealed that 39 were typeable, of which 85 and 12.5% were Cryptococcus neoformans var. grubii (serotype A) and Cryptococcus neoformans var. neoformans (serotype D), respectively. The prevalence of serotype D isolates in New York City appears to be significantly higher than indicated by previous studies of North American isolates.

Entities:  

Mesh:

Year:  2000        PMID: 10790132      PMCID: PMC86639     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents.

Authors:  N Poonwan; Y Mikami; S Poosuwan; J Boon-Long; N Mekha; M Kusum; K Yazawa; R Tanaka; K Nishimura; K Konyama
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

2.  The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharide.

Authors:  E E EVANS; J F KESSEL
Journal:  J Immunol       Date:  1951-08       Impact factor: 5.422

3.  Serotyping of Cryptococcus neoformans isolates from environmental and clinical sources in extreme southern Italy (Calabria and Sicily, central Mediterranean area).

Authors:  G Criseo; M Gallo
Journal:  Mycoses       Date:  1997-09       Impact factor: 4.377

4.  Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy.

Authors:  A M Tortorano; M A Viviani; A L Rigoni; M Cogliati; A Roverselli; A Pagano
Journal:  Mycoses       Date:  1997-11       Impact factor: 4.377

5.  Serotypes of Cryptococcus neoformans isolated from patients prior to and during the AIDS era in Thailand.

Authors:  S Sukroongreung; C Nilakul; O Ruangsomboon; W Chuakul; B Eampokalap
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

Review 6.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.

Authors:  W Cleare; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

8.  Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.

Authors:  S P Franzot; I F Salkin; A Casadevall
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. French Cryptococcosis Study Group.

Authors:  F Dromer; S Mathoulin; B Dupont; L Letenneur; O Ronin
Journal:  Clin Infect Dis       Date:  1996-07       Impact factor: 9.079

10.  Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.

Authors:  B P Currie; A Casadevall
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

View more
  25 in total

1.  The C2 domain protein Cts1 functions in the calcineurin signaling circuit during high-temperature stress responses in Cryptococcus neoformans.

Authors:  Eanas F Aboobakar; Xuying Wang; Joseph Heitman; Lukasz Kozubowski
Journal:  Eukaryot Cell       Date:  2011-10-14

2.  Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding.

Authors:  Chunquan Sheng; Zhenyuan Miao; Haitao Ji; Jianzhong Yao; Wenya Wang; Xiaoying Che; Guoqiang Dong; Jiaguo Lü; Wei Guo; Wannian Zhang
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

3.  Use of a suspension array for rapid identification of the varieties and genotypes of the Cryptococcus neoformans species complex.

Authors:  Mara R Diaz; Jack W Fell
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Novel fluconazole derivatives with promising antifungal activity.

Authors:  Nishad Thamban Chandrika; Sanjib K Shrestha; Huy X Ngo; Kaitlind C Howard; Sylvie Garneau-Tsodikova
Journal:  Bioorg Med Chem       Date:  2017-12-17       Impact factor: 3.641

Review 5.  Not your "typical patient": cryptococcal meningitis in an immunocompetent patient.

Authors:  Hilaire J Thompson
Journal:  J Neurosci Nurs       Date:  2005-06       Impact factor: 1.230

6.  Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain.

Authors:  Meiqing Shi; Shu Shun Li; Chunfu Zheng; Gareth J Jones; Kwang Sik Kim; Hong Zhou; Paul Kubes; Christopher H Mody
Journal:  J Clin Invest       Date:  2010-04-26       Impact factor: 14.808

7.  Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.

Authors:  B M Calvo; A L Colombo; O Fischman; A Santiago; L Thompson; M Lazera; F Telles; K Fukushima; K Nishimura; R Tanaka; M Myiajy; M L Moretti-Branchini
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

8.  Cryptococcus neoformans var. neoformans (serotype D) strains are more susceptible to heat than C. neoformans var. grubii (serotype A) strains.

Authors:  L R Martinez; J Garcia-Rivera; A Casadevall
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

9.  Fungal serotype-specific differences in bacterial-yeast interactions.

Authors:  Asan F Abdulkareem; Hiu Ham Lee; Mohammed Ahmadi; Luis R Martinez
Journal:  Virulence       Date:  2015       Impact factor: 5.882

10.  Growth and pigment production on D-tryptophan medium by Cryptococcus gattii, Cryptococcus neoformans, and Candida albicans.

Authors:  Stuart Chaskes; Susana Frases; Michael Cammer; Gary Gerfen; Arturo Casadevall
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.